Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Boise. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Boise at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
This is a parallel, Phase 2b, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of lunsekimig monotherapy in adult participants (aged 18 to 80 years, inclusive) with moderate-to-severe atopic dermatitis (AD). This study explores the efficacy and safety of 3 subcutaneous (SC) dose regimens of lunsekimig in adult participants with moderate-to-severe AD who have a documented history, within 6 months prior to baseline, of an inadequate
Sponsor: Sanofi
Check if you qualify for this atopic dermatitis clinical trial in Boise, ID
If you're searching for atopic dermatitis treatment options in Boise, ID, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boise research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.